These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 14617206)

  • 61. Analysis of preformed donor-specific anti-HLA antibodies characteristics for prediction of antibody-mediated rejection in kidney transplantation.
    Malheiro J; Tafulo S; Dias L; Martins LS; Fonseca I; Beirão I; Castro-Henriques A; Cabrita A
    Transpl Immunol; 2015 Mar; 32(2):66-71. PubMed ID: 25661873
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Increased macrophage density of cardiac allograft biopsies is associated with antibody-mediated rejection and alloantibodies to HLA antigens.
    Xu L; Collins J; Drachenberg C; Kukuruga D; Burke A
    Clin Transplant; 2014 May; 28(5):554-60. PubMed ID: 24580037
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Expression patterns of B cells in acute kidney transplant rejection.
    Carpio VN; Noronha Ide L; Martins HL; Jobim LF; Gil BC; Külzer AS; Loreto Mda S; Gonçalves LF; Manfro RC; Veronese FV
    Exp Clin Transplant; 2014 Oct; 12(5):405-14. PubMed ID: 25299368
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The significance of C4d staining with minimal histologic abnormalities.
    Haas M
    Curr Opin Organ Transplant; 2010 Feb; 15(1):21-7. PubMed ID: 19907328
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Memory CD4 T Cells Induce Antibody-Mediated Rejection of Renal Allografts.
    Gorbacheva V; Fan R; Fairchild RL; Baldwin WM; Valujskikh A
    J Am Soc Nephrol; 2016 Nov; 27(11):3299-3307. PubMed ID: 27020853
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Anti-CD20 antibody suppresses anti-HLA antibody formation in a HLA-A2 transgenic mouse model of sensitization.
    Wu GD; He Y; Chai NN; Toyoda M; Dunn R; Kehry MR; Klein AS; Jordan SC
    Transpl Immunol; 2008 Jul; 19(3-4):178-86. PubMed ID: 18595710
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Distinctive morphological features of antibody-mediated and T-cell-mediated acute rejection in pancreas allograft biopsies.
    Papadimitriou JC; Drachenberg CB
    Curr Opin Organ Transplant; 2012 Feb; 17(1):93-9. PubMed ID: 22227719
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Cardiac antibody-mediated rejection.
    Chin C
    Pediatr Transplant; 2012 Aug; 16(5):404-12. PubMed ID: 22500558
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Role of immunoglobulin (Ig)-G and IgM antibodies against donor human leukocyte antigens in organ transplant recipients.
    Stastny P; Ring S; Lu C; Arenas J; Han M; Lavingia B
    Hum Immunol; 2009 Aug; 70(8):600-4. PubMed ID: 19375468
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Summary of 2017 FDA Public Workshop: Antibody-mediated Rejection in Kidney Transplantation.
    Velidedeoglu E; Cavaillé-Coll MW; Bala S; Belen OA; Wang Y; Albrecht R
    Transplantation; 2018 Jun; 102(6):e257-e264. PubMed ID: 29470345
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Outcomes of Prolonged Treatment With Intravenous Immunoglobulin Infusions for Acute Antibody-mediated Rejection in Kidney Transplant Recipients.
    Bujnowska A; Michon M; Konopelski P; Hryniewiecka E; Jalbrzykowska A; Perkowska-Ptasinska A; Cieciura T; Zagozdzon R; Paczek L; Ciszek M
    Transplant Proc; 2018; 50(6):1720-1725. PubMed ID: 29961551
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Soluble BAFF Cytokine Levels and Antibody-Mediated Rejection of the Kidney Allograft.
    Slavcev A; Brozova J; Slatinska J; Sekerkova Z; Honsova E; Skibova J; Striz I; Viklicky O
    Arch Immunol Ther Exp (Warsz); 2016 Dec; 64(Suppl 1):47-53. PubMed ID: 28083608
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Post-transplantation antibody monitoring and HLA antibody epitope identification.
    Cai J; Terasaki PI
    Curr Opin Immunol; 2008 Oct; 20(5):602-6. PubMed ID: 18692134
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Diagnostic criteria of antibody-mediated rejection in kidney transplants.
    Mosquera Reboredo JM; Vázquez Martul E
    Nefrologia; 2011; 31(4):382-91. PubMed ID: 21738242
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Calcineurin Inhibitor Minimization With Ixazomib, an Investigational Proteasome Inhibitor, for the Prevention of Antibody Mediated Rejection in a Preclinical Model.
    Reese SR; Wilson NA; Huang G; Redfield RR; Zhong W; Djamali A
    Transplantation; 2015 Sep; 99(9):1785-95. PubMed ID: 25919767
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Outstanding questions in transplantation: B cells, alloantibodies, and humoral rejection.
    Chong AS; Rothstein DM; Safa K; Riella LV
    Am J Transplant; 2019 Aug; 19(8):2155-2163. PubMed ID: 30803121
    [TBL] [Abstract][Full Text] [Related]  

  • 77. B-lymphocytes support and regulate indirect T-cell alloreactivity in individual patients with chronic antibody-mediated rejection.
    Shiu KY; McLaughlin L; Rebollo-Mesa I; Zhao J; Semik V; Cook HT; Roufosse C; Brookes P; Bowers RW; Galliford J; Taube D; Lechler RI; Hernandez-Fuentes MP; Dorling A
    Kidney Int; 2015 Sep; 88(3):560-8. PubMed ID: 25830760
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Follicular Helper T Cell Derived Exosomes Promote B Cell Proliferation and Differentiation in Antibody-Mediated Rejection after Renal Transplantation.
    Yang J; Bi L; He X; Wang Z; Qian Y; Xiao L; Shi B
    Biomed Res Int; 2019; 2019():6387924. PubMed ID: 31223621
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Prevention trumps treatment of antibody-mediated transplant rejection.
    Knechtle SJ; Kwun J; Iwakoshi N
    J Clin Invest; 2010 Apr; 120(4):1036-9. PubMed ID: 20335653
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Chronic alloantibody mediated rejection.
    Smith RN; Colvin RB
    Semin Immunol; 2012 Apr; 24(2):115-21. PubMed ID: 22051115
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.